A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial-Reference-Cited by-同舟云学术

A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial

Published:2022-07 Issue:4 Volume:18 Page:e292-e302
ISSN:1969-6213
Container-title:EuroIntervention
language:
Short-container-title:

Author:

Zwart Bastiaan,Bor Willem Bor,de Veer Anne Johanna Wilhelmina Maria,Mahmoodi Bakhtawar Mahmoodi,Kelder Johannes Kelder,Lip Gregory Lip,Bhatt Deepak Bhatt,Cannon Christopher Cannon,ten Berg Jurriën ten Berg

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

2. 2018 ESC/EACTS Guidelines on myocardial revascularization

3. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

4. Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI

5. Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention;Journal of Clinical Medicine;2023-12-23

2. Non-ST Elevation Myocardial Infarction in the Elderly. Antithrombotic Therapy and Beyond;Reviews in Cardiovascular Medicine;2023-07-13

3. In the search of the ‘sweet spot’ for aspirin discontinuation time in AF patients post PCI;International Journal of Cardiology;2022-09

4. Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study;EuroIntervention;2022-07

5. Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction!;EuroIntervention;2022-07